Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...
Zapisane w:
Główni autorzy: | Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, Paolo Barraco, Stefano Passanisi, Antonella Gambadauro, Giuseppe Crisafulli, Mariella Valenzise, Sara Manti |
---|---|
Format: | Artigo |
Język: | angielski |
Wydane: |
2024
|
Dostęp online: | https://doi.org/10.3390/children11020170 https://www.mdpi.com/2227-9067/11/2/170/pdf?version=1706432217 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life
od: Francesca Galletta, i wsp.
Wydane: (2023) -
Impact of E-Cigarettes on Fetal and Neonatal Lung Development: The Influence of Oxidative Stress and Inflammation
od: Antonella Gambadauro, i wsp.
Wydane: (2025) -
Immune Response to Respiratory Viral Infections
od: Antonella Gambadauro, i wsp.
Wydane: (2024) -
Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: A randomized controlled study
od: Giovanni Battista Pajno, i wsp.
Wydane: (2011) -
Clinical Peculiarities in a Cohort of Patients with Wolfram Syndrome 1
od: Salzano, Giuseppina, i wsp.
Wydane: (2022)